Latest 5 articles from heartwire
- Sen Grassley questions top medical schools about ghostwriting
Nov 20, 2009 13:15 EDT - Stroke incidence related to PCI steady over 15 years
Nov 20, 2009 13:00 EDT - ALLHAT investigators report 10-year follow-up and stand by diuretics as first step antihypertensive treatment
Nov 19, 2009 14:00 EDT - Oral anticoagulants REDEEMed? Daily dabigatran "safe" with dual antiplatelets after MI
Nov 19, 2009 11:00 EDT - EFFECT: Public reporting of hospital performance improves quality of care?
Nov 19, 2009 10:00 EDT
Episode #1: Revascularization trials: Bypass vs PCI
Please note that the audio will stop and restart at the beginning of the file when submitting a comment.
Veuillez notez que le fichier audio s’arrête et recommence au début lorsqu’un commentaire est publié.
In this inaugural episode, Drs Topol and Teirstein focus on SYNTAX. From the basic questions--Does the trial have value? Has it affected clinical practice?--to the problematic issue of randomizing patients to a 20-minute intervention or a weeklong hospitalization, they also ponder what they have learned from revascularization trials and paper cuts as well as the whimsical image of performing PCI on CV surgeons.
Previous postsBillets précédents
Episode #4: Why is medicine resistant to change?
No commentsAucun commentaire |
Posted Oct 29, 2009
at 01:30 PM, EDT by Steven Publié le 10.29.2009 à 13h30 par Steven
at 01:30 PM, EDT by Steven Publié le 10.29.2009 à 13h30 par Steven
Episode #3: Percutaneous aortic-valve procedures
No commentsAucun commentaire |
Posted Jul 29, 2009
at 11:30 AM, EDT by Steven Publié le 07.29.2009 à 11h30 par Steven
at 11:30 AM, EDT by Steven Publié le 07.29.2009 à 11h30 par Steven
Episode #2: Dissecting "the cost conundrum": McAllen, Gawande, Obama, and healthcare reform in the US
2 comments2 commentaires |
Posted Jun 29, 2009
at 03:13 PM, EDT by Steven Publié le 06.29.2009 à 15h13 par Steven
at 03:13 PM, EDT by Steven Publié le 06.29.2009 à 15h13 par Steven
Also from theheart.org
About the Click and Rub Show
theheart.org brings you a freewheeling and unconventional exchange on the latest cardiology news and events through the eyes of thought leaders Drs Eric Topol and Paul Teirstein from Scripps Translational Research Institute.
We value the diverse opinions of our readership (that includes you!) -- share your thoughts by writing them in the comments box at left and stay tuned for new shows, posted on a monthly basis.
We value the diverse opinions of our readership (that includes you!) -- share your thoughts by writing them in the comments box at left and stay tuned for new shows, posted on a monthly basis.


CommentsCommentaires
This is a great, honest and finaly fare conversation.
Would like to hear other topics.
It is important to remember that a topic such as left main PCi vs CABG or for that matter 3 vessel disease PCI vs CABG needs to be discussed in a more detailed fashion than has been done in this first conversation. The interaction holds one’s interest but is too much on the surface.
There are after all other data ( Korean, French and German) already published on left main stenting in the recent past that merited mention to add more substance.
great idea for a medical 'radio show'!
It was difficult to ascertain if any definitive conclusions could be reached on the SYNTAX & FREEDOM TRIAL and CABG
And if these trial are 'underpowered' what would make these trials more balanced so that more conclusive conclusions could be concluded?